[TREATMENT OF MYASTHENIA].
D000324:Adrenocorticotropic Hormone; D003521:Cyclopropanes; D004837:Epinephrine; D005702:Galantamine; D006801:Humans; D006993:Hypnotics and Sedatives; D007531:Isoflurophate; D009020:Morphine; D009157:Myasthenia Gravis; D009388:Neostigmine; D003473:Neuromuscular Nondepolarizing Agents / Q000037:antagonists & inhibitors*; D009584:Nitrogen; D062025:Organophosphate Poisoning; D010277:Parasympathomimetics; D010758:Phosphorus; D011042:Poisons; D011802:Quinidine; D011803:Quinine; D013514:Surgical Procedures, Operative; D013950:Thymus Gland
D003521:Cyclopropanes; D006993:Hypnotics and Sedatives; D003473:Neuromuscular Nondepolarizing Agents; D010277:Parasympathomimetics; D011042:Poisons; D005702:Galantamine; D007531:Isoflurophate; D010758:Phosphorus; D009388:Neostigmine; D009020:Morphine; D000324:Adrenocorticotropic Hormone; C030797:cyclopropane; D011803:Quinine; D011802:Quinidine; D009584:Nitrogen; D004837:Epinephrine
CORTICOTROPIN; CURARIFORM ANTAGONISTS; CYCLOPROPANE; EPINEPHRINE; GALANTHAMINE; HYPNOTICS AND SEDATIVES; ISOFLUROPHATE; MORPHINE; MYASTHENIA GRAVIS; NEOSTIGMINE; NITROGEN; PARASYMPATHOMIMETICS; PHOSPHORUS POISONS, ORGANIC; QUINIDINE; QUININE; SURGERY, OPERATIVE; THYMUS GLAND
IL TRATTAMENTO DELLA MIASTENIA.